Business Context and Reporting Period
Company: Disc Medicine, Inc. (Nasdaq: IRON)
Filing Type: Form 8-K (Current Report)
Date of Report: June 12, 2023
Event: Suspension of a registered underwritten public offering (At-The-Market or "ATM" program).
Key Financial Metrics
This filing does not report operational financial metrics such as revenue, profit, cash flow, margins, or debt levels. The document focuses exclusively on capital market activities.
- ATM Program Capacity: Up to $100 million in common stock.
- Shares Sold Prior to Suspension: Approximately $20 million.
- Remaining Capacity: Approximately $80 million.
Material Changes
The Company notified SVB Securities LLC of the suspension of the sale of common stock under the Sales Agreement dated January 25, 2023. Consequently, no further sales of common stock will occur under this agreement until a new prospectus supplement or registration statement is filed with the SEC. The Sales Agreement itself remains in full force and effect.
Guidance, Outlook, and Risks
Outlook: The Company has suspended the offering but has not provided specific guidance on when the program might resume or the reasons for the suspension beyond the filing itself.
Risks and Contingencies: The filing contains forward-looking statements regarding the anticipated public offering and future expectations. Actual results may differ materially due to market conditions and the uncertainty of completing the offering on anticipated terms. Detailed risk factors are referenced in the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2023.
Investor Verification Checklist
- Verify the current cash position and runway in the most recent Form 10-Q (Q1 2023) to assess the impact of the suspended capital raise.
- Review the Form 10-Q for the quarter ended March 31, 2023, for detailed risk factors and operational updates.
- Monitor future SEC filings for a new prospectus supplement or registration statement required to resume the ATM program.
- Confirm the status of the Sales Agreement with SVB Securities LLC to ensure no other capital raising mechanisms are active.